GE Healthcare Signs GSK for Integration Project; Sharpens Informatics Strategy | GenomeWeb

GE Healthcare announced this week that it has signed a data-integration agreement with GlaxoSmithKline — the first informatics deal that the company has announced since its acquisition of Amersham Biosciences in April, and the first large pharmaceutical client that GE Healthcare’s informatics business has disclosed.

Under the terms of the agreement, GE Healthcare and GeneticXchange will collaborate with GSK to integrate internal and external data from the company’s genetics, discovery, and pre-clinical development R&D groups.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.